Hiroyuki Arai

10PUBLICATIONS
22CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 11, 2026
Genomic analysis of oesophageal carcinoma (EC) identifies recurrent mutations in histone methyltransferases as a distinctive subset.

|Jul 10, 2026
Activation of the endocytosis pathway stratifies subtypes and therapeutic sensitivity in colorectal cancer.

|Nov 05, 2024
Role of CD47 gene expression in colorectal cancer: a comprehensive molecular profiling study.

Hiroyuki Arai, Nishant Gandhi, Francesca Battaglin

|Apr 09, 2024
Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild-type metastatic colorectal cancer: A phase II trial (HYBRID).

Hiroyuki Arai, Takashi Tsuda, Yu Sunakawa

|Jan 11, 2024
CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value.

Francesca Battaglin, Yasmine Baca, Joshua Millstein

|Dec 23, 2023
Correlation of multiple endpoints in the first-line chemotherapy of advanced gastric cancer: Pooled analysis of individual patient data from Japanese Phase III trials.

Hiroyuki Arai, Madoka Takeuchi, Wataru Ichikawa

Pageof 2

Frequent Collaborators

5 joint publications

Heinz-Josef Lenz

4 joint publications

Emil Lou

2 joint publications

Igor Astsaturov

2 joint publications

Richard M Goldberg